A carregar...
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 diabetes (T2D) or cardiovascular diseases (CVD). Extra...
Na minha lista:
| Publicado no: | Obes Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Ltd.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785422/ https://ncbi.nlm.nih.gov/pubmed/33426364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.obmed.2020.100312 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|